Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8146299
[patent_doc_number] => 08163305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Targeted cross-linked nanoparticles and their use in vivo gene delivery'
[patent_app_type] => utility
[patent_app_number] => 12/195261
[patent_app_country] => US
[patent_app_date] => 2008-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 10486
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163305.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195261
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195261 | Targeted cross-linked nanoparticles and their use in vivo gene delivery | Aug 19, 2008 | Issued |
Array
(
[id] => 5416942
[patent_doc_number] => 20090042829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Nucleic Acid-Lipopolymer Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/186945
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11469
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042829.pdf
[firstpage_image] =>[orig_patent_app_number] => 12186945
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/186945 | Nucleic Acid-Lipopolymer Compositions | Aug 5, 2008 | Abandoned |
Array
(
[id] => 6520148
[patent_doc_number] => 20100203115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES'
[patent_app_type] => utility
[patent_app_number] => 12/671235
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5565
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203115.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671235
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671235 | ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES | Jul 29, 2008 | Abandoned |
Array
(
[id] => 8982092
[patent_doc_number] => 08513206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Crosslinked PEI nanoparticle transfection agents for delivery of biomolecules with increased efficiency'
[patent_app_type] => utility
[patent_app_number] => 12/181798
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 6965
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12181798
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/181798 | Crosslinked PEI nanoparticle transfection agents for delivery of biomolecules with increased efficiency | Jul 28, 2008 | Issued |
Array
(
[id] => 8264649
[patent_doc_number] => 20120164073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 12/219223
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13136
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12219223
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/219223 | Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles | Jul 16, 2008 | Abandoned |
Array
(
[id] => 5296096
[patent_doc_number] => 20090011022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Use of deuterium oxide for treatment of virus-based diseases of the skin'
[patent_app_type] => utility
[patent_app_number] => 12/168583
[patent_app_country] => US
[patent_app_date] => 2008-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15272
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20090011022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12168583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/168583 | Use of deuterium oxide for treatment of herpes virus-based diseases of the skin | Jul 6, 2008 | Issued |
Array
(
[id] => 6563331
[patent_doc_number] => 20100272812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/666677
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7149
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272812.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666677
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666677 | RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM | Jun 24, 2008 | Abandoned |
Array
(
[id] => 4949890
[patent_doc_number] => 20080306016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications'
[patent_app_type] => utility
[patent_app_number] => 12/130643
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19869
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130643 | Nucleic acid functionalized nanoparticles for therapeutic applications | May 29, 2008 | Issued |
Array
(
[id] => 5348785
[patent_doc_number] => 20090004146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Humanised Baculovirus'
[patent_app_type] => utility
[patent_app_number] => 12/123821
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5082
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12123821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/123821 | Humanised Baculovirus | May 19, 2008 | Abandoned |
Array
(
[id] => 4663202
[patent_doc_number] => 20080254109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM'
[patent_app_type] => utility
[patent_app_number] => 12/122561
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5570
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254109.pdf
[firstpage_image] =>[orig_patent_app_number] => 12122561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/122561 | LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM | May 15, 2008 | Abandoned |
Array
(
[id] => 4675680
[patent_doc_number] => 20080213309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/116031
[patent_app_country] => US
[patent_app_date] => 2008-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17524
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213309.pdf
[firstpage_image] =>[orig_patent_app_number] => 12116031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/116031 | Multi-antigenic alphavirus replicon particles and methods | May 5, 2008 | Issued |
Array
(
[id] => 8981584
[patent_doc_number] => 08512697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Delivery of micro- and nanoparticles with blood platelets'
[patent_app_type] => utility
[patent_app_number] => 12/150562
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10670
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12150562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150562 | Delivery of micro- and nanoparticles with blood platelets | Apr 28, 2008 | Issued |
Array
(
[id] => 5928877
[patent_doc_number] => 20110038836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Device and Method for Transfecting Cells for Therapeutic Use'
[patent_app_type] => utility
[patent_app_number] => 12/674151
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13663
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674151
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674151 | Device and Method for Transfecting Cells for Therapeutic Use | Apr 22, 2008 | Abandoned |
Array
(
[id] => 5385280
[patent_doc_number] => 20090226525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Self-assembling nanoparticle drug delivery system'
[patent_app_type] => utility
[patent_app_number] => 12/082154
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22684
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226525.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082154
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082154 | Self-assembling nanoparticle drug delivery system | Apr 8, 2008 | Abandoned |
Array
(
[id] => 8543564
[patent_doc_number] => 08318856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid'
[patent_app_type] => utility
[patent_app_number] => 12/733061
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 32
[patent_no_of_words] => 13648
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733061 | Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid | Apr 3, 2008 | Issued |
Array
(
[id] => 4534283
[patent_doc_number] => 07888326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5'
[patent_app_type] => utility
[patent_app_number] => 12/062178
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 34660
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12062178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/062178 | Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5 | Apr 2, 2008 | Issued |
Array
(
[id] => 4563834
[patent_doc_number] => 07846725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Antibody composition-producing cell in which enzyme expression is inhibited by RNAi'
[patent_app_type] => utility
[patent_app_number] => 12/060617
[patent_app_country] => US
[patent_app_date] => 2008-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 73
[patent_no_of_words] => 77458
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12060617
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/060617 | Antibody composition-producing cell in which enzyme expression is inhibited by RNAi | Mar 31, 2008 | Issued |
Array
(
[id] => 4886393
[patent_doc_number] => 20080260725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Tag and target delivery system'
[patent_app_type] => utility
[patent_app_number] => 12/079681
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7283
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12079681
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/079681 | Tag and target delivery system | Mar 27, 2008 | Abandoned |
Array
(
[id] => 7555331
[patent_doc_number] => 08067232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase'
[patent_app_type] => utility
[patent_app_number] => 12/048343
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 74
[patent_no_of_words] => 77436
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12048343
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/048343 | Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase | Mar 13, 2008 | Issued |
Array
(
[id] => 4644589
[patent_doc_number] => 08022195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Vectors encoding cell growth and adhesion factors for simultaneous growth and adhesion of cells'
[patent_app_type] => utility
[patent_app_number] => 12/075657
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 15344
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022195.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075657
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075657 | Vectors encoding cell growth and adhesion factors for simultaneous growth and adhesion of cells | Mar 12, 2008 | Issued |